CCJ vs. UEC: Which Uranium Stock Deserves a Place in Your Portfolio?

Cameco (CCJ) reported strong Q2 2025 results, with revenues up 47% to $634M and EPS surging 410%, benefiting from fixed-price contracts and its fuel services segment amid recovering uranium prices and a robust long-term nuclear energy outlook. Conversely, Uranium Energy Corp (UEC) recorded no Q3 2025 revenues and a wider adjusted loss of $0.06/share due to increased operating expenses and a strategy to withhold sales. While both are positioned for growth from global nuclear expansion, CCJ is favored for its stable earnings and more attractive valuation compared to UEC's volatile revenue, projected losses, and higher forward price-to-sales multiple.

Analysis

The uranium sector presents a compelling long-term thesis, buoyed by renewed nuclear energy ambitions in the U.S. and India, supporting a spot price recovery to approximately $73.50 per pound. Within this context, Cameco (CCJ) and Uranium Energy Corp. (UEC) exhibit sharply divergent operational and financial profiles. Cameco demonstrated significant fundamental strength, reporting a 47% year-over-year revenue increase to $634 million and a 410% surge in adjusted EPS for Q2 2025. This performance was driven by a 40% rise in sales volume and the stability of its fixed-price contracts, which resulted in a 5% increase in its realized Canadian dollar price despite a 17% decline in the U.S. dollar spot price. Conversely, Uranium Energy Corp. posted no revenue in its most recent quarter, opting to withhold sales amid market volatility, which, combined with a 73% increase in operating expenses, widened its adjusted loss to six cents per share. While UEC holds a strategic U.S. resource portfolio and is restarting production, its financial outlook is weak, with analysts forecasting continued losses for fiscal 2025 and 2026 and downward revisions to earnings estimates. Cameco's guidance is positive, with 2025 revenue projected to grow 12.1% and EPS to surge 151%. Although both companies trade at premium valuations, UEC’s forward price-to-sales multiple of 52.92X is substantially higher than CCJ's 12.86X, indicating a significant valuation discrepancy relative to their current profitability and risk profiles.

Key Decisions for Investors

• Cameco (CCJ) presents a more stable investment vehicle for uranium exposure, given its proven ability to generate strong revenue and earnings growth through its long-term contracts and diversified fuel services segment, effectively mitigating spot price volatility.
• Investors should be cautious of Uranium Energy Corp. (UEC) due to its current lack of revenue, widening losses driven by surging operating expenses, negative earnings estimate revisions, and a very high forward sales multiple of 52.92X.
• Despite UEC's stronger year-to-date stock performance, the significant disparity in financial health and valuation suggests that CCJ may be a more prudent long-term holding for risk-averse investors focused on fundamentals.
• Key indicators to monitor are the progress of UEC's production restarts and its cash burn rate, as its strategy is highly dependent on a future sustained rise in uranium prices to monetize its inventory profitably.